Steven R. Hagen, SVP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 5,897 shares at $14.80 ($88K) on 2014-05-09, disclosed to the SEC on 2014-05-13.
Seasonal sale ($88k) by SVP Pharmaceutical Development & Mfg — this insider has traded AMRI in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.80 | 897 | $13K | 15.0% |
| 2 | $14.80 | 2,500 | $37K | 41.8% |
| 3 | $15.27 | 2,500 | $38K | 43.2% |
| Total | $15.00 avg | 5,897 | $88K | 100% |
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |